Sensitivity of baker's yeast to disulfiram (DSF) and hypersensitivity of a mutant devoid of Cu, Zn-superoxide dismutase to this compound is reported, demonstrating that yeast may be a simple convenient eukaryotic model to study the mechanism of DSF toxicity. DSF was found to induce oxidative stress in yeast cells demonstrated by increased superoxide production and decrease of cellular glutathione content. Anoxic atmosphere and hydrophilic antioxidants (ascorbate, glutathione, dithiothreitol, cysteine, and N-acetylcysteine) ameliorated DSF toxicity to yeast indicating that oxidative stress plays a critical role in the cellular action of DSF.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3247666 | PMC |
| http://dx.doi.org/10.1007/s10565-011-9200-z | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Disulfiram-Loaded Nanoparticles Inhibit Long-Term Proliferation on Preadipocytes.
Int J Nanomedicine
December 2024
Tecnologico de Monterrey, Institute for Obesity Research, Monterrey, México.
Introduction: Disulfiram (DSF) reduces insulin resistance and weight gain in obese mice. However, the effect on adipose tissue is unexplored due to their high instability under physiological conditions, limiting clinical applications. Thus, it is meaningful to develop a DSF carrier for sustained release to adipose tissue.
View Article and Find Full Text PDFOne stone, three birds: Construction of Cu/ZIF-8@DSF@GOx/HA nanoplatform for synergistic starvation therapy enhanced chemo-/chemodynamic therapy.
Nanomedicine
November 2024
College of Chemistry & Pharmacy, Northwest A&F University, Yangling 712100, Shaanxi, China; Shenzhen Research Institute, Northwest A&F University, Shenzhen 518000, China. Electronic address:
Article Synopsis
- Disulfiram (DSF), a traditional drug for alcohol dependence, has shown potential as an effective chemotherapy agent, particularly by using copper.
- A new nanoparticle formula (CZDGH) was developed to deliver DSF, copper, and glucose oxidase (GOx) directly to tumor cells, enhancing treatment efficacy.
- This approach not only depletes tumor glucose and enhances DSF's anticancer effects but also increases oxidative stress to combat multidrug resistance in cancer cells.
Biophysical Analysis of Vip3Aa Toxin Mutants Before and After Activation.
Int J Mol Sci
November 2024
Institute of Molecular Biosciences, Mahidol University, Salaya, Phuttamonthon 73170, Nakhon Pathom, Thailand.
Cry toxins from are effective biopesticides that kill lepidopteran pests, replacing chemical pesticides that indiscriminately attack both target and non-target organisms. However, resistance in susceptible pests is an emerging problem. also produces vegetative insecticidal protein (Vip3A), which can kill insect targets in the same group as Cry toxins but using different host receptors, making the combined application of Cry and Vip3A an exciting possibility.
View Article and Find Full Text PDFTumor specific in situ synthesis of therapeutic agent for precision cancer therapy.
J Nanobiotechnology
October 2024
Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Article Synopsis
- * Researchers developed a new nanosystem called DSF@CuPDA-PEGM, which uses disulfiram (an alcohol dependence drug) and copper ions to generate a toxic antitumor compound on-site in cancer cells.
- * This new nanosystem shows high effectiveness against various cancer types while reducing harm to healthy cells and enhancing the immune system's response to cancer treatment, improving outcomes for patients receiving immunotherapy.
Injectable Hydrogel-Encapsulating Pickering Emulsion for Overcoming Lenvatinib-Resistant Hepatocellular Carcinoma via Cuproptosis Induction and Stemness Inhibition.
Polymers (Basel)
August 2024
Department of Hepatobiliary Surgery I, General Surgery Center, Zhujiang Hospital, Southern Medical University, Guangzhou 510280, China.
Article Synopsis
- Lenvatinib resistance (LenR) in hepatocellular carcinoma (HCC) complicates treatment and is mainly caused by increased cancer cell stemness, leading to higher mortality rates.
- Disulfiram (DSF), in conjunction with copper ions, can help fight LenR by targeting cancer cell stemness and inducing cell death (cuproptosis), but it has limitations such as poor solubility and potential toxicity.
- To improve its efficacy and stability, DSF and copper oxide nanoparticles were combined to create a gel formulation (DSF@CuO Gel) that effectively releases the treatment in the tumor environment, showing promise in reducing cancer cell resistance and enhancing therapeutic outcomes in HCC.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!